Rock Springs Capital Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.93M | Buy |
11,300
+8,500
| +304% | +$4.46M | 0.37% | 60 |
|
|
2025
Q1 | $1.78M | Buy |
+2,800
| New | +$1.78M | 0.1% | 79 |
|
|
2017
Q4 | – | Sell |
-16,000
| Closed | -$7.15M | – | 149 |
|
|
2017
Q3 | $7.15M | Hold |
16,000
| – | – | 0.33% | 89 |
|
|
2017
Q2 | $7.86M | Buy |
16,000
+900
| +6% | +$442K | 0.4% | 75 |
|
|
2017
Q1 | $5.85M | Sell |
15,100
-4,400
| -23% | -$1.7M | 0.34% | 84 |
|
|
2016
Q4 | $7.16M | Buy |
19,500
+2,500
| +15% | +$918K | 0.48% | 59 |
|
|
2016
Q3 | $6.83M | Hold |
17,000
| – | – | 0.43% | 66 |
|
|
2016
Q2 | $5.94M | Buy |
17,000
+500
| +3% | +$175K | 0.44% | 75 |
|
|
2016
Q1 | $5.95M | Buy |
16,500
+5,500
| +50% | +$1.98M | 0.5% | 68 |
|
|
2015
Q4 | $5.97M | Hold |
11,000
| – | – | 0.45% | 74 |
|
|
2015
Q3 | $5.12M | Hold |
11,000
| – | – | 0.42% | 78 |
|
|
2015
Q2 | $5.61M | Buy |
11,000
+1,000
| +10% | +$510K | 0.41% | 82 |
|
|
2015
Q1 | $4.52M | Buy |
10,000
+1,000
| +11% | +$452K | 0.42% | 75 |
|
|
2014
Q4 | $3.69M | Buy |
+9,000
| New | +$3.69M | 0.43% | 72 |
|
|
2014
Q3 | – | Sell |
-7,500
| Closed | -$2.12M | – | 87 |
|
|
2014
Q2 | $2.12M | Hold |
7,500
| – | – | 0.38% | 69 |
|
|
2014
Q1 | $2.25M | Buy |
+7,500
| New | +$2.25M | 0.52% | 57 |
|